Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATELLITE study of telmisartan + amlodipine with optional hydrochlorothiazide in arterial hypertension
2023-504812-13-00Phase 4Completed
- Sponsor
- Krka
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 4, open-label trial of telmisartan, amlodipine and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Krka. Primary endpoint: Mean absolute change of 24-hour systolic blood pressure. Started May 2024; status: completed.
02
Drugs
telmisartanamlodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2023-504812-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504812-13-00.